Canakinumab 150mg powder for solution for injection vials

SNOMED code
16592911000001100
Active compound
Canakinumab
Preferred name basis
rINN - Recommended International Non-proprietary
Prescribable
Caution - AMP level prescribing advised
Non-availability
Actual Products not Available
Non-availability date
Dose form
Discrete
Dose size and units
1 vial, vial
Ingredients
Canakinumab — 150 mg based on ingredient substance
Form & Route
solutioninjection.subcutaneous
Powder for solution for injection, Subcutaneous
Controlled drug
No Controlled Drug Status

Products

Ilaris 150mg powder for solution for injection vials (Novartis Pharmaceuticals UK Ltd)

Ilaris 150mg powder for solution for injection vials

SNOMED code
16591411000001103
Supplier
Novartis Pharmaceuticals UK Ltd
Licensed as
Medicines - MHRA/EMA
Availability restrictions
Not available
Licensed route
Subcutaneous
Pack name & codeStatusGTIN, EAN barcodesPricePrescribingReimbursementPack
Ilaris 150mg powder for solution for injection vials (Novartis Pharmaceuticals UK Ltd) 1 vial
16591511000001104   ref. pack
Discontinued


Legal category: POM
5010678909012
No Price Available
 
previously: £9,927
• Personally Administered
  • • Prescription Charges
  • • Dispensing Fees
  • • Special container
  • • Discount not deducted - automatic

Reference packs

Canakinumab 150mg powder for solution for injection vials 1 vial
SNOMED code
16591311000001105
Quantity and unit
1 vial
Packs